Can I Join a Clinical Trial After Chemotherapy?
Yes, many clinical trials specifically seek patients who have already received chemotherapy. Second-line and later-line trials test treatments for patients whose cancer has progressed after initial therapy. A washout period between your last chemo cycle and trial enrollment is typically required.
Clinical Trials After First-Line Treatment
Many mesothelioma clinical trials are specifically designed for patients who have already received and progressed on chemotherapy. These "second-line" and "later-line" trials test treatments intended for patients whose cancer did not respond to or has returned after initial therapy. According to ClinicalTrials.gov, a significant portion of active mesothelioma trials require prior chemotherapy as an eligibility criterion.
In fact, having received prior chemotherapy can open doors to trials that are unavailable to newly diagnosed patients. Immunotherapy trials, CAR T-cell studies, and targeted therapy trials frequently enroll patients who have completed at least one line of standard chemotherapy.
Washout Period and Recovery
Most trials require a washout period between your last chemotherapy dose and enrollment. This period — typically 2 to 6 weeks — allows the effects of chemotherapy to clear your body and gives your organ function and blood counts time to recover. The specific washout period is defined in each trial's protocol.
During this interval, your oncologist will monitor your recovery through blood tests and clinical assessments. To meet trial eligibility, your kidney function, liver function, and blood counts must recover to specified levels. Most patients recover sufficiently within the required washout period, particularly if their chemotherapy side effects were manageable.
Types of Post-Chemo Trials
Immunotherapy trials are among the most common options for previously treated mesothelioma patients. Checkpoint inhibitors, combination immunotherapy regimens, and novel immune-activating agents are all being tested in the second-line setting. Targeted therapies directed at specific tumor mutations are another growing category.
Some trials test maintenance strategies — treatments given after initial chemotherapy response to extend the duration of remission. Others test entirely new drug classes or combination approaches that may work through mechanisms unrelated to prior chemotherapy.
Planning Your Next Steps
Discuss clinical trial options with your oncologist before completing your current treatment so that planning for the next step can begin promptly. If your cancer progresses after chemotherapy, having identified potential trials in advance can reduce the gap between treatments.
Continuing to pursue legal compensation for asbestos exposure while exploring clinical trials ensures that financial resources are available to support your ongoing treatment journey.
- Second-Line Trials: Specifically designed for patients who progressed after first-line chemotherapy
- Washout Period: Typically 2–6 weeks between last chemo and trial enrollment
- Recovery: Organ function and blood counts must recover to meet trial eligibility thresholds
- Options: Immunotherapy, targeted therapy, and combination trials often accept previously treated patients
Reviewed by: Rod De Llano, J.D. — Texas Bar — 30+ years mesothelioma litigation
Last updated: March 15, 2026
Sources: National Cancer Institute, ClinicalTrials.gov
Our attorneys have handled mesothelioma cases for over 30 years. We can evaluate your situation, explain every option available to you, and answer your questions — all at no cost and with no obligation.
Request a Free Consultation
Your information is confidential and protected. We typically respond within 24 hours.
Call 1-800-400-1805 for immediate help.